Category Archives: Decentralization

The most important elements of emotional IQ for healthcare leaders today

Posted on by • Posted in Decentralization, Delegation, Emotional IQ, Empathy, Humility, Leadership, Leadership Emotional State, Leadership Integrity, Success, Vulnerable • Leave a comment

https://mailchi.mp/f9bf1e547241/gist-weekly-february-23-2024?e=d1e747d2d8

At a recent dinner with my good friend and colleague Dave Blom, the former President and CEO of Ohio Health, he and I discussed the difficulties of leading and managing complex healthcare organizations in the post-Covid era.

We agreed that the leadership issues that matter most right now center around the ability of executives to possess and demonstrate an authentic emotional IQ. 

Taking care of patients—in fact, taking care of communities—is not only managerially complicated but also emotionally testing. 

Success cannot be achieved by technical and clinical excellence alone; rather, it must be built on a platform of an emotional IQ that is supported, valued, and shared by the entire organization.
 


The below list is what Dave and I settled on as the most important elements of emotional IQ for healthcare leaders today, and we think that leadership teams that fully embrace these behaviors unlock a higher level of organizational trust, as well as corporate and managerial integrity.
 


–Empathy. 

A leader needs to understand and share the feelings of his or her entire organization, as well as understand the difference between sympathy and empathy: sympathy is a passive emotion while empathy is an active emotion. A leader with empathy not only notes the problem but immediately moves to be of help at either the personal or organizational level, whichever is required.
 


–Vulnerability. 

Historically, executive leadership, especially in corporate situations, has been trained and encouraged not to show emotion or weakness. But organizations are changing, and the composition of the today’s workforce is different. The patient care process is emotional in and of itself, and daily operational interactions demand a different kind of leadership—a leadership that is comfortable with both emotion and weakness.
 


–Humility. 

Executives who show humility are willing to ask for help, and don’t insist on everything being done their way; they are quick to forgive and are known for their patience. Humility supports a collaborative and cooperative leadership model, which has at its core a heavy dose of decentralization and delegation.

The Decentralization of Clinical Trials

Posted on by • Posted in Clinical Research, Clinical Trials, Competition, Decentralization, Disruption, Disruptive Technology • Leave a comment
https://us17.campaign-archive.com/?e=d1e747d2d8&u=526c5e99ee0439b6f83f7c051&id=6da6d4f543
Medable and CVS Health partner to expand clinical trial access - Drug Discovery and Development

CVS Health announced it has struck a deal with Medable, a decentralized clinical trial software company, incorporating its offerings into MinuteClinics to help reach more patients for late-stage clinical trials. With over 40 percent of Americans living near a CVS pharmacy, CVS says it can help gather data and manage patients at MinuteClinic locations, and through its home infusion service, Coram. CVS has already cut its teeth in the clinical research space by conducting COVID-19 vaccine and treatment trials and testing home dialysis machines, and said it plans to engage 10M patients and open up to 150 community research sites this year.

The Gist: With this deal, CVS Health joins companies like Verily, Alphabet’s life sciences subsidiary, in taking advantage of patient appetite for clinical trials without regularly traveling to a research center, which became difficult during the pandemic.

Clinical research is a $50B market that has largely revolved around academic medical centers in large urban areas, which could see their dominance of the research business challenged. CVS’s entry into this space could lower the barriers to entry for community health systems to expand into clinical research. 

Ultimately, the decentralization of the clinical trials business is a win for patients, especially groups that have historically been under-represented in medical research, including rural and lower-income individuals. They may find participation through a local pharmacy—or even completely virtually from the comfort of their own home—much more accessible, affordable, and convenient.